Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders

S. Sehra, L. Chugh, S. V. Gangal

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Background. The conventional immunotherapy used for treating allergic individuals may at times lead to varying degrees of anaphylactic reaction. Liposomes have been proposed as a vehicle for safe and effective allergen- specific immunotherapy as multiple injections of liposome-entrapped allergen (LEA) have been shown to reduce specific IgE response and induce specific IgG response in BALB/c mice. Objective and methods. To elucidate the effect of LEA on polarization of T-cell responses, its effect on the relative production of TH1/TH2 type cytokines (namely IL-2, IL-4 and IFN-γ by commercially available ELISA kits and immunoglobulin profile as measured by ELISA) were studied. Histamine release on challenge of immunized mice was measured to examine the efficacy of LEA in preventing anaphylactic reactions. Results. Measurement of cytokine levels in serum and spleen cell culture supernatants of BALB/c mice injected repeatedly with either free allergen (FA) or LEA (three mice per group) indicate that LEA preferentially induces a TH1-type of response dominated by IFN-γ, and IL-2 production. Further, it was also shown that immunization of mice with FA or LEA and subsequent challenge with a large dose of the sensitizing allergen leads to fatal systemic reactions in 50-65% of the animals treated with FA, whereas no mortality was observed in mice injected with LEA. Analysis of IgG subclasses in sera of mice immunized with LEA revealed a six-fold higher production of IgG1 antibodies than mice immunized with FA. Serum IgG2a, IgG2b, IgG3 and IgM responses were also enhanced in the group of mice immunized with LEA in comparison with mice injected with FA. Conclusion. The results indicate that LEA confers protection against anaphylaxis to mice due to their ability to induce a high IFN-γ:IL-4 ratio which may lead to decreased synthesis of IgE and reduced histamine release on challenge with FA.

Original languageEnglish (US)
Pages (from-to)1530-1537
Number of pages8
JournalClinical and Experimental Allergy
Volume28
Issue number12
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Liposomes
Immunotherapy
Allergens
Anaphylaxis
Immunoglobulin G
Histamine Release
Interleukin-4
Immunoglobulin E
Interleukin-2
Serum
Enzyme-Linked Immunosorbent Assay
Cytokines
Immunologic Desensitization
Antibody Formation
Immunoglobulin M
Immunoglobulins
Immunization

Keywords

  • Immunomodulators
  • Immunotherapy
  • Liposomes
  • TH1
  • TH2

ASJC Scopus subject areas

  • Immunology

Cite this

Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders. / Sehra, S.; Chugh, L.; Gangal, S. V.

In: Clinical and Experimental Allergy, Vol. 28, No. 12, 1998, p. 1530-1537.

Research output: Contribution to journalArticle

@article{b21f6a9d582e4a3cb598de299966afe8,
title = "Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders",
abstract = "Background. The conventional immunotherapy used for treating allergic individuals may at times lead to varying degrees of anaphylactic reaction. Liposomes have been proposed as a vehicle for safe and effective allergen- specific immunotherapy as multiple injections of liposome-entrapped allergen (LEA) have been shown to reduce specific IgE response and induce specific IgG response in BALB/c mice. Objective and methods. To elucidate the effect of LEA on polarization of T-cell responses, its effect on the relative production of TH1/TH2 type cytokines (namely IL-2, IL-4 and IFN-γ by commercially available ELISA kits and immunoglobulin profile as measured by ELISA) were studied. Histamine release on challenge of immunized mice was measured to examine the efficacy of LEA in preventing anaphylactic reactions. Results. Measurement of cytokine levels in serum and spleen cell culture supernatants of BALB/c mice injected repeatedly with either free allergen (FA) or LEA (three mice per group) indicate that LEA preferentially induces a TH1-type of response dominated by IFN-γ, and IL-2 production. Further, it was also shown that immunization of mice with FA or LEA and subsequent challenge with a large dose of the sensitizing allergen leads to fatal systemic reactions in 50-65{\%} of the animals treated with FA, whereas no mortality was observed in mice injected with LEA. Analysis of IgG subclasses in sera of mice immunized with LEA revealed a six-fold higher production of IgG1 antibodies than mice immunized with FA. Serum IgG2a, IgG2b, IgG3 and IgM responses were also enhanced in the group of mice immunized with LEA in comparison with mice injected with FA. Conclusion. The results indicate that LEA confers protection against anaphylaxis to mice due to their ability to induce a high IFN-γ:IL-4 ratio which may lead to decreased synthesis of IgE and reduced histamine release on challenge with FA.",
keywords = "Immunomodulators, Immunotherapy, Liposomes, TH1, TH2",
author = "S. Sehra and L. Chugh and Gangal, {S. V.}",
year = "1998",
doi = "10.1046/j.1365-2222.1998.00448.x",
language = "English (US)",
volume = "28",
pages = "1530--1537",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders

AU - Sehra, S.

AU - Chugh, L.

AU - Gangal, S. V.

PY - 1998

Y1 - 1998

N2 - Background. The conventional immunotherapy used for treating allergic individuals may at times lead to varying degrees of anaphylactic reaction. Liposomes have been proposed as a vehicle for safe and effective allergen- specific immunotherapy as multiple injections of liposome-entrapped allergen (LEA) have been shown to reduce specific IgE response and induce specific IgG response in BALB/c mice. Objective and methods. To elucidate the effect of LEA on polarization of T-cell responses, its effect on the relative production of TH1/TH2 type cytokines (namely IL-2, IL-4 and IFN-γ by commercially available ELISA kits and immunoglobulin profile as measured by ELISA) were studied. Histamine release on challenge of immunized mice was measured to examine the efficacy of LEA in preventing anaphylactic reactions. Results. Measurement of cytokine levels in serum and spleen cell culture supernatants of BALB/c mice injected repeatedly with either free allergen (FA) or LEA (three mice per group) indicate that LEA preferentially induces a TH1-type of response dominated by IFN-γ, and IL-2 production. Further, it was also shown that immunization of mice with FA or LEA and subsequent challenge with a large dose of the sensitizing allergen leads to fatal systemic reactions in 50-65% of the animals treated with FA, whereas no mortality was observed in mice injected with LEA. Analysis of IgG subclasses in sera of mice immunized with LEA revealed a six-fold higher production of IgG1 antibodies than mice immunized with FA. Serum IgG2a, IgG2b, IgG3 and IgM responses were also enhanced in the group of mice immunized with LEA in comparison with mice injected with FA. Conclusion. The results indicate that LEA confers protection against anaphylaxis to mice due to their ability to induce a high IFN-γ:IL-4 ratio which may lead to decreased synthesis of IgE and reduced histamine release on challenge with FA.

AB - Background. The conventional immunotherapy used for treating allergic individuals may at times lead to varying degrees of anaphylactic reaction. Liposomes have been proposed as a vehicle for safe and effective allergen- specific immunotherapy as multiple injections of liposome-entrapped allergen (LEA) have been shown to reduce specific IgE response and induce specific IgG response in BALB/c mice. Objective and methods. To elucidate the effect of LEA on polarization of T-cell responses, its effect on the relative production of TH1/TH2 type cytokines (namely IL-2, IL-4 and IFN-γ by commercially available ELISA kits and immunoglobulin profile as measured by ELISA) were studied. Histamine release on challenge of immunized mice was measured to examine the efficacy of LEA in preventing anaphylactic reactions. Results. Measurement of cytokine levels in serum and spleen cell culture supernatants of BALB/c mice injected repeatedly with either free allergen (FA) or LEA (three mice per group) indicate that LEA preferentially induces a TH1-type of response dominated by IFN-γ, and IL-2 production. Further, it was also shown that immunization of mice with FA or LEA and subsequent challenge with a large dose of the sensitizing allergen leads to fatal systemic reactions in 50-65% of the animals treated with FA, whereas no mortality was observed in mice injected with LEA. Analysis of IgG subclasses in sera of mice immunized with LEA revealed a six-fold higher production of IgG1 antibodies than mice immunized with FA. Serum IgG2a, IgG2b, IgG3 and IgM responses were also enhanced in the group of mice immunized with LEA in comparison with mice injected with FA. Conclusion. The results indicate that LEA confers protection against anaphylaxis to mice due to their ability to induce a high IFN-γ:IL-4 ratio which may lead to decreased synthesis of IgE and reduced histamine release on challenge with FA.

KW - Immunomodulators

KW - Immunotherapy

KW - Liposomes

KW - TH1

KW - TH2

UR - http://www.scopus.com/inward/record.url?scp=0032410425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032410425&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2222.1998.00448.x

DO - 10.1046/j.1365-2222.1998.00448.x

M3 - Article

VL - 28

SP - 1530

EP - 1537

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 12

ER -